Krka Reports 30% Profit Growth in Q1
Novo Mesto, 14 May - The Novo mesto-based pharma group Krka generated a net profit of EUR 55.1m in the three months to the end of March, a rise of 30% over the same period last year, despite 3% lower sales at EUR 289.3m.
The rest of this news item is available to subscribers.
The news item consists of 900 characters (without spaces) or 189 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.